MK-8245

N/A

Report date: 2024/12/11 14:40:03
NME

Base Information

Drug NameMK-8245
Drug Alias NameMK-8245
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcyl-CoA desaturase inhibitors
TargetsAcyl-CoA desaturase
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme LLC
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A